NONSPECIFIC CERVICALGIA: EPIDEMIOLOGY, OCCURRENCE FACTORS, CURRENT MEDICAL TREATMENT CONCEPTS

Download full text PDF
Issue: 
5
Year: 
2015

L. Shirokova (1), MD; M. Mokrousova (1,2); R. Bulanov (2) 1 -Yaroslavl State Medical University 2 -Clinical Hospital Three, Yaroslavl

The paper analyzes the epidemiology and development factors of vertebrogenic cervicalgia. It discusses the current concepts of medical therapy for nonspecific chronic neck pains.
Keywords: 
nonspecific cervicalgia
epidemiology
risk factors
medical therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Levin O.S. Diagnostika i lechenie vertebrogennoj shejnoj radikulopatii // Consilium Medicum. Nevrologija. Revmatologija. – 2010; 1: 59–63.
  2. Kramchatnov P.R. Povyshenie effektivnosti protivobolevoj terapii pri degenerativnyh porazhenijah pozvonochnika // Farmateka. – 2012; 14: 45–9.
  3. Cassidy J., Carroll L., Cote´ P. The Saskatchewan Health and Back Pain Survey. The prevalence of low back pain and related disability in Saskatchewan adults // Spine. – 1998; 23: 1860–7.
  4. Croft P., Lewis M., Papageorgiou A. et al. Risk factors for neck pain: a longitudinal study in the general population // Pain. – 2001; 93: 317–25.
  5. Fejer R., Kyvik K., Hartvigsen J. The prevalence of neck pain in the world population: a systematic critical review of the literature // Eur. Spine J. – 2006; 15 (6): 834–48.
  6. Kato S., Takeshita K., Matsudaira K. et al. Normative score and cut-off value of the Neck Disability Index // J. Orthop. Sci. – 2012 Aug 16. (Epub ahead of print).
  7. Chiu T., Leung A., Lam P. Neck pain in Hong Kong: a telephone survey on consequences and health service utilization // Spine. – 2010; 35 (21): 1088–95.
  8. McLean S., May S., Klaber-Moffett J. et al. Risk factors for the onset of non specific neck pain: a systematic review // J. Epidemiol. Community Health. – 2010; 64: 565–72.
  9. Enthoven P., Skargren E., Oberg B. Clinical course in patients seeking primary care for back or neck pain: a prospective 5-year follow-up of outcome and health care consumption with subgroup analysis // Spine. – 2004; 29: 2458–65.
  10. adhakrishnan K., Litchy W., O’Fallon W. et al. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990 // Brain. – 1994; 117: 325–35.
  11. Fejer R., Leboeuf-Yde C. Does back and neck pain become more common as you get older? Asystematic literature review // Chiropr. Man. Therap. – 2012; 20 (1): 24–32.
  12. Gorshunova N.K., Medvedev N.V. Myshechnye boli kak problema patsienta v ambulatornoj praktike // Spravochnik fel'dshera i akusherki. – 2011; 10: 19–26.
  13. Finnerup N., Jensen T. Spinal cord injury pain-mechanisms and treatment // Eur. J. Neurol. – 2004; 11: 73–82.
  14. Grigor'eva V.N., Gustov A.V. Psihologicheskaja harakteristika bol'nyh s nevrologicheskimi projavlenijami pojasnichnogo osteohondroza // Zhurn. nevrol. i psihiatr. im. S.S. Korsakova. – 1997; 3: 12–5.
  15. Gorshunova N.K., Medvedev N.V. Sindrom dorsalgii // Spravochnik fel'dshera i akusherki. – 2009; 9: 17–26
  16. Osipova N.A., Abuzarova G.R., Petrova V.V. Printsipy primenenija anal'geticheskih sredstv pri ostroj i hronicheskoj boli. Klinicheskie reko-mendatsii / M.: FGBU «MNIOI im. P.A. Gertsena» Minzdravsotsrazvitija Rossii, 2010; 67 s.
  17. Ahmed M., Al-Badr A. Lornoxicam // Profiles Drug Subst. Excip. Relat. Methodol. – 2011; 36: 205–39.
  18. Herrmann W., Geertsen M. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study // Int. J. Clin. Pract. – 2009; 63 (11): 1613–21.
  19. Kukes A.K., Starodubtseva V.G. Klinicheskaja farmakologija i farmakoterapija / M.: GEOTAR-Media, 2012; 832 s.
  20. Berry H., Hutchinson D. Tizanidine and ibuprofen in acute low–backpain: Results of a double–blindmulticentre study in general practice // J. Intern. Med. Res. – 1988; 16: 83–91.
  21. Sirdalud Ternilin Asia–Pacific Study group. Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasm // Curr. Ther. Res. – 1998; 59: 13–22.
  22. Oknin V.Ju. Baklofen v nevrologicheskoj praktike // Lechenie nervnyh boleznej. – 2002; 3: 34–7.
  23. Fedotova A.V., Voznesenskaja T.G. Baklofen pri lechenii bolej v spine (myshechno-tonicheskih i miofastsial'nyh bolevyh sindromov) // Lechenie nervnyh boleznej. – 2004; 2: 19–22.
  24. Koreshkina M.I. Baklosan (baklofen) v lechenii bolej v spine: rezul'taty mnogotsentrovogo issledovanija BRAVO // Zhurn. nevrol. i psihi-at. – 2009; 8: 68–9.
  25. Parfenov V.A. Diagnoz i lechenie pri ostryh boljah v nizhnej chasti spiny // Rus. med. zhurn. – 2007; 15 (6): 506–9.
  26. Badokin V.V. Znachenie vospalenija v razvitii i techenii osteoartroza // Consilium Medicum. – 2009; 11 (9): 91–5.
  27. Ignatova A.V. Opyt primenenija preparata Hondrogard v sostave lechebno-medikamentoznyh blokad v lechenii fasetochnogo sindroma i dis-funktsii kresttsovo-podvzdoshnogo sochlenenija v ambulatornyh uslovijah // RMZh. – 2013; 5: 1–3